Angelini Pharma
  • Global Site
  • Harmonia Mentis
  • Angelini Pharma
  • About us

    • Who we are
    • Vision, Mission and Values
    • Our History
    • Our Leadership team
  • Core Areas

    • Brain Health
    • Epilepsy
  • Products
  • Partnering

    • Partnerships & Initiatives
  • Our Responsibility

    • Sustainability & Social Initatives
    • Diversity & Inclusion
    • Ethics & Compliance
    • Quality Policy
    • Transparency
  • Media

    • Media Contact
  • Careers
  • Contact
  • Open main menu
  • Open main menu
  • Search

    Search

  1. Angelini Pharma
  2. About Us
  3. Our History

Our History

Boccette e scatole antiche di medicinali

Share

  • Twitter
  • Facebook
  • Linkedin
  1. 1919 – 1950 Beginnings

    It all began in 1919 in Ancona, an Italian city on the shores of the Adriatic Sea. Here, Francesco Angelini set up a small pharmaceutical laboratory. Then in 1941, he founded ACRAF, Aziende Chimiche Riunite Angelini Francesco, producing and distributing pharmaceuticals.

    In the aftermath of World War II, anaemia was a widespread problem in Italy. The company was the first to import a key treatment for this condition, vitamin B12, to Italy. It was sold under the name of Dobetin® and was a major success.

  2. The 50s Transformation

    At the start of the 1950s, activities were expanded to Rome where the headquarters are located.

    The company also diversified into mass consumer goods.

    In 1958, Angelini Pharma launched Tachipirina®, an anti-flu drug based on paracetamol. Today, Tachipirina® is the most frequently prescribed drug by paediatricians and one of the top three medicines sold in Italy.

  3. 1960 – 1970 The golden age

    In these years, the first original molecules discovered by Angelini pharmaceutical research began production. A series of important and innovative molecules were discovered and developed in the 1960s and 1970s, including oxolamine (anti-cough), benzydamine (anti-inflammatory), trazodone (antidepressant) and dapiprazole (anti-glaucoma).

  4. The 80s The power of marketing

    Angelini Pharma started its expansion abroad by creating production facilities and commercial structures in Spain and Portugal. Activities in the Iberian Peninsula began in 1979 with the acquisition of Barcelona’s Lepori Group.

    In these years, the company understood the importance of advertising and marketing of its products.
    In 1985, came the first example of marketing techniques applied to pharmaceutical products in Italy. Angelini Pharma saw great potential for the analgesic ibuprofen and launched it as an analgesic for headache under the brand name of Moment®. It was a tremendous success!

  5. 1990 – 2011 Internationalisation

    From the start of the new century, Angelini Group began a series of strategic acquisitions to reinforce its international footprint, first in the Iberian Peninsula and later in other European countries, particularly in Central and Eastern Europe.

    In 2000, Amuchina®, a Genoa-based company that produced disinfectants and sanitisers, joined the Group and, in 2003, Angelini Pharma entered the phytotherapy and supplements market with Body Spring®. In 2011, the company purchased the Infasil® brand from P&G, an Italian leader in deodorants and personal care products.

  6. 2012 – 2022 Strategic Focus

    Angelini Pharma continued its path of internationalisation. The Company signed agreements with leading multinational pharmaceutical companies to market a wide range of products: Resilient® (prolonged-release lithium salt) and Latuda® (lurasidone hydrochloride) for mental health; Vellofent® (fentanil) and Tachifene® (paracetamol and ibuoprofen) for pain and inflammation.

    In 2020, Angelini Pharma acquired the ThermaCare® global business rights (excl. US). 

    In 2021, Angelini Pharma strengthened its positioning in Brain Health with the acquisition of Arvelle Therapeutics.

See also

  1. Who We Are

    Who We Are
  2. Vision, Mission and Values

    Vision, Mission and Values
  3. Our Leadership team

    Our Leadership team
  • Top Employer Europe 2025
  • Terms of use
  • Privacy
  • Cookie Policy
  • Contact
  • Site map
  • Cookie settings
  • Linkedin
  • Facebook
  • Instagram
  • YouTube

Angelini Pharma Zug S.p.A., Rom, branch Zug - Zählerweg 6, 6300 Zug, Switzerland / APPIAN: 18745
Copyright 2025 © Angelini S.p.a. - All Rights Reserved

Part of Angelini Industries

Close menu